These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 33920054)
1. From Oncogenic Signaling Pathways to Single-Cell Sequencing of Immune Cells: Changing the Landscape of Cancer Immunotherapy. Derakhshani A; Rostami Z; Safarpour H; Shadbad MA; Nourbakhsh NS; Argentiero A; Taefehshokr S; Tabrizi NJ; Kooshkaki O; Astamal RV; Singh PK; Taefehshokr N; Alizadeh N; Silvestris N; Baradaran B Molecules; 2021 Apr; 26(8):. PubMed ID: 33920054 [TBL] [Abstract][Full Text] [Related]
2. A Systematic Review of the Tumor-Infiltrating CD8 Shadbad MA; Asadzadeh Z; Hosseinkhani N; Derakhshani A; Alizadeh N; Brunetti O; Silvestris N; Baradaran B Front Immunol; 2021; 12():734956. PubMed ID: 34603316 [TBL] [Abstract][Full Text] [Related]
3. A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery. Shadbad MA; Safaei S; Brunetti O; Derakhshani A; Lotfinejad P; Mokhtarzadeh A; Hemmat N; Racanelli V; Solimando AG; Argentiero A; Silvestris N; Baradaran B Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440380 [TBL] [Abstract][Full Text] [Related]
4. Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies? Hosseinkhani N; Derakhshani A; Kooshkaki O; Abdoli Shadbad M; Hajiasgharzadeh K; Baghbanzadeh A; Safarpour H; Mokhtarzadeh A; Brunetti O; Yue SC; Silvestris N; Baradaran B Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167514 [TBL] [Abstract][Full Text] [Related]
5. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Zhang Y; Zhang Z Cell Mol Immunol; 2020 Aug; 17(8):807-821. PubMed ID: 32612154 [TBL] [Abstract][Full Text] [Related]
6. Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics. Liu W; Puri A; Fu D; Chen L; Wang C; Kellis M; Yang J Clin Exp Metastasis; 2024 Aug; 41(4):313-332. PubMed ID: 38064127 [TBL] [Abstract][Full Text] [Related]
7. The circadian rhythm key gene Wu G; Ren H; Hu Q; Ma H; Chen H; Zhou L; Xu K; Ding L Front Immunol; 2023; 14():1115809. PubMed ID: 37275880 [TBL] [Abstract][Full Text] [Related]
8. Dendritic cell-based cancer immunotherapy in the era of immune checkpoint inhibitors: From bench to bedside. Ghorbaninezhad F; Asadzadeh Z; Masoumi J; Mokhtarzadeh A; Kazemi T; Aghebati-Maleki L; Shotorbani SS; Shadbad MA; Baghbanzadeh A; Hemmat N; Bakhshivand M; Baradaran B Life Sci; 2022 May; 297():120466. PubMed ID: 35271882 [TBL] [Abstract][Full Text] [Related]
9. Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors. Gibellini L; De Biasi S; Porta C; Lo Tartaro D; Depenni R; Pellacani G; Sabbatini R; Cossarizza A Front Immunol; 2020; 11():490. PubMed ID: 32265933 [TBL] [Abstract][Full Text] [Related]
10. High-throughput single-сell sequencing in cancer research. Jia Q; Chu H; Jin Z; Long H; Zhu B Signal Transduct Target Ther; 2022 May; 7(1):145. PubMed ID: 35504878 [TBL] [Abstract][Full Text] [Related]
11. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer. Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241 [TBL] [Abstract][Full Text] [Related]
12. Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery. de Sousa E; Lérias JR; Beltran A; Paraschoudi G; Condeço C; Kamiki J; António PA; Figueiredo N; Carvalho C; Castillo-Martin M; Wang Z; Ligeiro D; Rao M; Maeurer M Front Immunol; 2021; 12():592031. PubMed ID: 34335558 [TBL] [Abstract][Full Text] [Related]
13. Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells. Alissafi T; Hatzioannou A; Legaki AI; Varveri A; Verginis P J Autoimmun; 2019 Nov; 104():102310. PubMed ID: 31421963 [TBL] [Abstract][Full Text] [Related]
14. Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers. Mushtaq MU; Papadas A; Pagenkopf A; Flietner E; Morrow Z; Chaudhary SG; Asimakopoulos F J Immunother Cancer; 2018 Jul; 6(1):65. PubMed ID: 29970158 [TBL] [Abstract][Full Text] [Related]
15. Oncogenic pathways that affect antitumor immune response and immune checkpoint blockade therapy. Zhao X; Subramanian S Pharmacol Ther; 2018 Jan; 181():76-84. PubMed ID: 28720430 [TBL] [Abstract][Full Text] [Related]
16. Role of cell surface proteoglycans in cancer immunotherapy. Espinoza-Sánchez NA; Götte M Semin Cancer Biol; 2020 May; 62():48-67. PubMed ID: 31336150 [TBL] [Abstract][Full Text] [Related]
17. The current landscape of single-cell transcriptomics for cancer immunotherapy. Guruprasad P; Lee YG; Kim KH; Ruella M J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33601414 [TBL] [Abstract][Full Text] [Related]
18. Oncogenic signaling pathways associated with immune evasion and resistance to immune checkpoint inhibitors in cancer. Kobayashi Y; Lim SO; Yamaguchi H Semin Cancer Biol; 2020 Oct; 65():51-64. PubMed ID: 31874279 [TBL] [Abstract][Full Text] [Related]
19. Checkpoint Inhibitors: Applications for Autoimmunity. Tocheva AS; Mor A Curr Allergy Asthma Rep; 2017 Sep; 17(10):72. PubMed ID: 28956259 [TBL] [Abstract][Full Text] [Related]
20. Recharacterizing Tumor-Infiltrating Lymphocytes by Single-Cell RNA Sequencing. Zhang L; Zhang Z Cancer Immunol Res; 2019 Jul; 7(7):1040-1046. PubMed ID: 31262773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]